Astle Christopher 4
4 · Zymeworks Inc. · Filed Mar 11, 2022
Insider Transaction Report
Form 4
Zymeworks Inc.ZYME
Astle Christopher
SVP & Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-03-10+125,000→ 125,000 totalExercise: $7.00Exp: 2032-03-09→ Common Shares (125,000 underlying)
Footnotes (1)
- [F1]Stock options vest as follows: (i) 25% of underlying shares on first anniversary of grant date and (ii) remainder of underlying shares in 36 equal monthly installments on last day of month following first anniversary of grant date.